Xortx announces date for rescheduled special meeting of shareholders

Calgary, alberta, oct. 25, 2023 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its earlier press release, the special meeting of shareholders has been rescheduled to 10:00 a.m. (calgary time) on friday, october 27, 2023 (the “meeting”).
XRTX Ratings Summary
XRTX Quant Ranking